![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, June 13, 2013 4:28:41 PM
Beneficial Ownership of OUR Common Stock
The following table sets forth certain information, as of June 3, 2013 with respect to holdings of our common stock by (i) each person known by us to be the beneficial owner of more than 5% of the total number of shares of common stock outstanding as of such date, (ii) each of our directors and executive officers, and (iii) all directors and executive officers as a group. Except as otherwise indicated, the address of each person is c/o CytoCore, Inc., 414 N. Orleans Street, Suite 510, Chicago, Illinois 60610.
Name and Address of Beneficial Owner Amount and Nature
of Beneficial
Ownership (1)
Percentage
of Class (1)
Robert F. McCullough 167,690,706 (2) 66.90 %
Augusto Ocana 9,090,836 3.63 %
Mauro Scimia
5,959,750 2.38 %
Xavier Carbonell 6,569,823 2.62 %
John H. Abeles, M.D. 4,063,098 (3) 1.62 %
Richard A. Domanik, Ph.D. 172,272 (4) *
Alexander M. Milley 4,652,950 (5) 1.86 %
All officers and directors as a group (7 persons) 198,199,435 79.07 %
____________________________
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM